Asprimax 1000 mg/g
Country: Germany
Language: English
Source: HMA (Heads of Medicines Agencies)
Summary of Product characteristics
(SPC)
13-03-2012
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
acetylsalicylic acid sodium salicylate 1000 mg/g
Available from:
Chevita Tierarzneimittel GmbH
ATC code:
QN02BA04
Pharmaceutical form:
Powder for oral solution
Therapeutic group:
sodium salicylate
Therapeutic area:
Cattle Young, Pigs Food
Authorization date:
2011-03-10
Summary of Product characteristics
SPC, Labelling and Package leaflet - EN version
Duocylat 1000 mg/g
1/16
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
SPC, Labelling and Package leaflet - EN version
Duocylat 1000 mg/g
2/16
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
DUOCYLAT 1000 MG/G
Powder for oral solution for calves and pigs
Sodium salicylate
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
1 gram of powder contains:
ACTIVE SUBSTANCE: Sodium salicylate 1000 mg.
EXCIPIENTS: For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Powder for oral solution.
White or off-white flakes.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Calves and pigs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Calves: Supportive treatment of pyrexia in acute respiratory disease, in combination with
appropriate (e.g. anti-infective) therapy.
Pigs:
To promote recovery of respiration and to reduce coughing in respiratory tract
infections with concurrent antibiotic therapy.
For the treatment of inflammation in combination with concurrent antibiotic therapy.
4.3
CONTRAINDICATIONS
Do not administer in case of severe liver or kidney disorder.
Do not administer to neonates or to very young calves less than 2 weeks of age and piglets less
than 4 weeks of age.
Do not use in case of gastrointestinal ulcerations and chronic gastrointestinal disease.
Do not use in case of damaged haematopoietic system, in case of blood coagulation disorders or
in case of haemorrhagic diathesis.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Diseased animals may have a changed drinking water or
Read the complete document
